SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-317826
Filing Date
2018-11-05
Accepted
2018-11-05 08:00:35
Documents
4
Period of Report
2018-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d642576d8k.htm 8-K 23868
2 EX-99.1 d642576dex991.htm EX-99.1 13050
3 GRAPHIC g642576g1103011414862.jpg GRAPHIC 2421
4 GRAPHIC g642576g1103011415174.jpg GRAPHIC 3454
  Complete submission text file 0001193125-18-317826.txt   46603
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 181158783
SIC: 2834 Pharmaceutical Preparations